Alyeska Investment Group
INBS icon

Alyeska Investment Group’s Intelligent Bio Solutions INBS Stock Holding History

Alyeska Investment Group’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$127K Buy
+37,956
New +$262K ﹤0.01% 601
2025
Q4 		– Sell
-67,349
Closed -$687K – 656
2025
Q3 		$687K Buy
67,349
+5,960
+10% +$96.1K ﹤0.01% 549
2025
Q2 		$1.06M Hold
61,389
– – ﹤0.01% 504
2025
Q1 		$884K Buy
+61,389
New +$1.15M ﹤0.01% 448
2024
Q4 		– Sell
-20,620
Closed -$357K – 607
2024
Q3 		$357K Buy
+20,620
New +$321K ﹤0.01% 495
2024
Q2 		– Sell
-20,620
Closed -$527K – 618
2024
Q1 		$864K Buy
+20,620
New +$854K 0.01% 419

Other funds holding INBS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CW
Curio Wealth Annapolis, Maryland $293M AUM 14.23% 1-Year Est. Return